The World Health Organization congratulates Brazil for its remarkable achievement in eliminating lymphatic filariasis. This victory is a testament to the country's commitment to global health.
Brasilia, Brazil – 1 October 2024:
The World Health Organization (WHO) has congratulated Brazil for achieving a significant milestone in public health: the elimination of lymphatic filariasis as a public health problem. This accomplishment is a testament to the country's unwavering commitment to combating neglected tropical diseases.
Lymphatic filariasis, commonly known as elephantiasis, is a debilitating parasitic disease transmitted by mosquitoes. It can cause severe swelling, disability, and social stigma. For centuries, this disease has afflicted millions worldwide, leaving a lasting impact on individuals and communities.
Brazil's journey to eliminate lymphatic filariasis was marked by a comprehensive approach that included mass drug administration, vector control activities, and robust surveillance. The country's dedication to these efforts was evident in its development of a national plan to combat the disease in 1997 and its subsequent implementation of integrated actions.
The elimination of lymphatic filariasis was also a key goal of the Brasil Saudável program, a multisectoral initiative launched by President Luiz Inácio Lula da Silva in February 2024. This program aimed to address socially determined diseases through a whole-of-government approach and civil society participation.
Brazil's success in eliminating lymphatic filariasis is a testament to its strong healthcare system, specialized laboratory expertise, and robust surveillance. It serves as an inspiration for other countries facing similar challenges in the fight against neglected tropical diseases.
Globally, Brazil joins a select group of 19 other countries and territories that have been validated by WHO for eliminating lymphatic filariasis. This achievement is a significant step towards the global goal of eradicating this disease.
While Brazil has achieved a remarkable victory, the fight against lymphatic filariasis continues in other parts of the world. There are still three endemic countries in the Americas—Dominican Republic, Guyana, and Haiti—that require mass drug administration to stop transmission and achieve elimination.
The elimination of lymphatic filariasis is a testament to the power of collaboration, dedication, and effective public health interventions. It is a significant milestone that brings hope to millions of people affected by this debilitating disease.